• On sale!
search

CERULISIN * GTT OTO FL 20ML

  • IBSA Farmaceutici Italia S.r.l.
  • 020157018

Ear drops indicated for the removal of ear wax.

info_outline View product sheet
Final Price €14.90

Volume discounts

Quantity Unit discount You Save
2 10% €2.98
5 15% €11.18
10 25% €37.25
Quantity
check_circle Available
Shipped within 24 h
  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Other products Others products at unbeatable price

IBSA Farmaceutici Italia S.r.l.

Discover all products

CERULISIN * GTT OTO FL 20ML

Therapeutic indications

For the dissolution of earwax and epidermal plugs. In dressing for cleaning operating cavities following interventions in the middle ear.

Dosage and method of use

Posology The usual dose is equal to the contents of the dropper. For hard caps, the instillations are performed 2-3 times a day and the treatment must be continued for 3-5 days in relation to the amount of ear wax to be extracted. Do not exceed the recommended dose. Method of administration Topical use. The contents of a dropper, preferably warmed, is poured, after tilting the head, into the ear canal. The subject should remain in this position for 5-10 minutes. Afterwards, the ear is washed with warm water.

Contraindications

§ Hypersensitivity to the active ingredients. § Middle ear diseases (otitis, perforated eardrum).

Side effects

Prolonged use of CERULISIN can cause sensitization phenomena. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it/content/segnalazioni-reazioni-avverse .

Special warnings

The use of the medicine does not involve special precautions. Do not use in cases of perforated eardrum. The use, especially if prolonged, of the medicine can give rise to sensitization phenomena. If this occurs, discontinue treatment and institute appropriate therapy. Do not use the medicine after the expiry date indicated on the package. Report the onset of any undesirable effects not described in the package leaflet, see section 4.8.

Pregnancy and breastfeeding

There are no known harmful effects at normal therapeutic doses.

Expiry and retention

None.

Interactions with other drugs

There are no known interactions between CERULISIN and other drugs.

Overdose

No cases of overdose have been reported.

Active principles

1 ml contains: • active ingredients: dimethylbenzene 46 mg, sweet almond oil 870 mg.

Excipients

Not present

020157018

Data sheet

Packaging
drops 20 ml
Product Type
HUMAN DRUG
ATC code
S02DC
ATC description
Indifferent preparations
Therapeutic Group
Orl: local otologists
Active principle
xylene
Class
C.
Pharmaceutical form
drops
Type of Administration
headset
Container
dropper vial
Quantity
1 vial / vial / vial
Capacity
20 milliliters
Quantity of the Active Ingredient
5G
Recipe required
OTC - self-medication medicine
chat Comments (0)
Fast Order